{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:52:49Z","timestamp":1760597569847,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.leukres.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T23:22:35Z","timestamp":1362007355000},"page":"536-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Cheng","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3324\/haematol.2009.013359","article-title":"Mantle cell lymphoma","volume":"94","author":"Pileri","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2013.02.006_bib0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br J Haematol"},{"year":"2008","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.leukres.2013.02.006_bib0015"},{"key":"10.1016\/j.leukres.2013.02.006_bib0020","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-02-179739","article-title":"How I treat mantle cell lymphoma","volume":"114","author":"Ghielmini","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.02.006_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.767","article-title":"Update on the molecular biology of mantle cell lymphoma","volume":"24","author":"Bertoni","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0030","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study group classification of non-Hodgkin's lymphoma The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.02.006_bib0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.leukres.2013.02.006_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.leukres.2013.02.006_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BJ20051368","article-title":"Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies","volume":"393","author":"Lerner","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.leukres.2013.02.006_bib0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00915791","article-title":"Regulation of the immune response by prostaglandins","volume":"3","author":"Goodwin","year":"1983","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0055","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.leukres.2013.02.006_bib0060","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1073\/pnas.0806152105","article-title":"Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2013.02.006_bib0065","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/gcc.20920","article-title":"t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2","volume":"50","author":"Nagel","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2013.02.006_bib0070","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ijc.25785","article-title":"Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemia","volume":"129","author":"Zhang","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2013.02.006_bib0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.leukres.2007.10.009","article-title":"Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia","volume":"32","author":"Xu","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.02.006_bib0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2013.02.006_bib0085","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.02.006_bib0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06526.x","article-title":"Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH","volume":"137","author":"Parry-Jones","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2141.2008.07199.x","article-title":"Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis","volume":"142","author":"Katzenberger","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0100","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/ijc.26222","article-title":"MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL","volume":"130","author":"Dong","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2013.02.006_bib0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.02.006_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bone.2008.02.021","article-title":"Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts","volume":"43","author":"Pekkinen","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.leukres.2013.02.006_bib0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543780903485642","article-title":"Targeting cancer with phosphodiesterase inhibitors","volume":"19","author":"Savai","year":"2010","journal-title":"Expert Opin Invest Drug"},{"key":"10.1016\/j.leukres.2013.02.006_bib0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(01)00764-9","article-title":"Epinephrine inhibits invasion of oral squamous carcinoma cells by modulating intracellular cAMP","volume":"176","author":"Yamanaka","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2013.02.006_bib0125","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-07-0097","article-title":"Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase","volume":"67","author":"McEwan","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.02.006_bib0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cdp.2006.07.008","article-title":"Cyclic adenosine monophosphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells","volume":"30","author":"Al-Wadei","year":"2006","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.leukres.2013.02.006_bib0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions","volume":"12","author":"Soderling","year":"2000","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/bbrc.2000.2661","article-title":"Identification of human PDE7B, a cAMP-specific phosphodiesterase","volume":"271","author":"Sasaki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.leukres.2013.02.006_bib0145","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuroscience.2005.01.050","article-title":"Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain","volume":"132","author":"Reyes-Irisarri","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.leukres.2013.02.006_bib0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0155","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.02.006_bib0160","first-page":"11","article-title":"Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives","volume":"91","author":"Salaverria","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2013.02.006_bib0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2141.2002.03260.x","article-title":"Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization","volume":"116","author":"Allen","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.02.006_bib0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/10428190290016890","article-title":"Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases","volume":"43","author":"Au","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2013.02.006_bib0175","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s12032-011-0096-5","article-title":"TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage","volume":"29","author":"Dong","year":"2012","journal-title":"Med Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:58:07Z","timestamp":1758934687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0145212613000441"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.02.006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}